CVE-2026-83129: Oracle Sales · Improper Access Control
Affects Oracle SalesSource CVE Database V5
Not known to be exploited · CVSS 7.7 High.
Data as of 30 Oct 2026, 20:25 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 27% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:N/A:NExploitation evidence
Disclosed: evidence found.
CVE published 15 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Oracle CorporationOracle Sales | Affected
| Fixed in– |
Mavencom.oracle/OracleSalespkg:maven/com.oracle/OracleSalesOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Oracle has released a Critical Security Patch Update in September 2026 that includes fixes for this vulnerability. Customers should apply the relevant patches from this update to affected Oracle Sales versions 12.2.3 through 12.2.15 without delay. Oracle strongly recommends remaining on actively supported versions and promptly applying security patches to prevent exploitation. No additional mitigation steps are indicated beyond patching.
Description
CVE-2026-83129 is a high-severity vulnerability in Oracle Sales, part of the Oracle E-Business Suite. It affects versions 12.2.3 through 12.2.15. The flaw allows a low privileged attacker with network access via HTTP to compromise Oracle Sales, potentially leading to unauthorized access to critical or all accessible data within Oracle Sales. The vulnerability has a CVSS 3.1 base score of 7.7, indicating significant confidentiality impact with no required user interaction. Oracle has included this vulnerability in its September 2026 Critical Security Patch Update, which provides targeted fixes across multiple products including Oracle Sales.